BECTON, DICKINSON AND COMPANY Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax
BECTON, DICKINSON AND COMPANY (BDX) reported Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax of $14.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Other Income
us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax · last filed 2026-08-06
- BECTON, DICKINSON AND COMPANY other comprehensive income (loss), cash flow hedge, gain (loss), after reclassification and tax for the quarter ending 2026-06-30 was $14.00M.
- BECTON, DICKINSON AND COMPANY other comprehensive income (loss), cash flow hedge, gain (loss), after reclassification and tax for fiscal 2025 was $27.00M.
| Period end | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax 3 month | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax 9 month | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax 12 month |
|---|---|---|---|
| 2026-06-30 | $14.00M 10-Q · filed 2026-08-06 | $28.00M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $27.00M 10-K · filed 2025-11-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |